Predictors of Acute Renal Injury Study (Paris) among HIV-positive individuals: Design and methods

Celia Corona Villalobos, Michael G. Shlipak, Adrienne Tin, Chirag Parikh, Richard D Moore, Eric Vittinghoff, Jose Monroy-Trujillo, Mohamed Atta, Michelle M. Estrella

Research output: Contribution to journalArticle

Abstract

Background: Acute kidney injury (AKI), which is common among HIV-positive individuals, may contribute to the excess burden of chronic kidney disease (CKD) in this patient population; however, conventional clinical methods to detect AKI do not capture kidney injury sufficiently early to prevent irreversible damage. Further, large observational and interventional studies of AKI generally exclude HIV-positive persons in spite of their disproportionate risk. Methods: The Predictors of Acute Renal Injury Study (Paris) is a prospective observational cohort study among HIV-positive individuals established to determine the ability of candidate kidney injury biomarkers to predict future hospitalized clinical AKI, to characterize hospitalized subclinical AKI, and to discern the risk of progressive kidney disease following subclinical and clinical AKI. Among the candidate kidney injury markers, we will select the most promising to translate into a clinically viable, multiplex panel of urinary biomarkers which we will integrate with clinical factors to develop a model prognostic of risks for AKI and subsequent kidney function decline. This study has a targeted enrollment of 2000 participants. The overall follow-up of participants consists of two phases: 1) a 5-year active follow-up phase which involves serial evaluations at enrollment, annual clinic visits, and among participants who are hospitalized during this period, an evaluation at index hospitalization and 3 and 12 months post-hospitalization; and 2) a subsequent passive follow-up phase for the duration that the participant receives medical care at The Johns Hopkins Hospital. Discussions: This study will serve as an important resource for future studies of AKI by establishing a repository with both ambulatory and inpatient biospecimens, a resource that is currently lacking in existing HIV clinical cohorts and studies of AKI. Upon completion of this study, the resulting prognostic model which will incorporate results from the multiplex HIV-AKI Risk Pane could serve as a pharmacodynamic endpoint for early phase therapeutic candidates for AKI.

Original languageEnglish (US)
Article number289
JournalBMC Nephrology
Volume18
Issue number1
DOIs
StatePublished - Sep 7 2017

Fingerprint

Acute Kidney Injury
HIV
Kidney
Observational Studies
Wounds and Injuries
Hospitalization
Cohort Studies
Biomarkers
Kidney Diseases
Ambulatory Care
Chronic Renal Insufficiency
Inpatients

ASJC Scopus subject areas

  • Nephrology

Cite this

Predictors of Acute Renal Injury Study (Paris) among HIV-positive individuals : Design and methods. / Corona Villalobos, Celia; Shlipak, Michael G.; Tin, Adrienne; Parikh, Chirag; Moore, Richard D; Vittinghoff, Eric; Monroy-Trujillo, Jose; Atta, Mohamed; Estrella, Michelle M.

In: BMC Nephrology, Vol. 18, No. 1, 289, 07.09.2017.

Research output: Contribution to journalArticle

@article{1907381d76f74f2198ddab70ece04303,
title = "Predictors of Acute Renal Injury Study (Paris) among HIV-positive individuals: Design and methods",
abstract = "Background: Acute kidney injury (AKI), which is common among HIV-positive individuals, may contribute to the excess burden of chronic kidney disease (CKD) in this patient population; however, conventional clinical methods to detect AKI do not capture kidney injury sufficiently early to prevent irreversible damage. Further, large observational and interventional studies of AKI generally exclude HIV-positive persons in spite of their disproportionate risk. Methods: The Predictors of Acute Renal Injury Study (Paris) is a prospective observational cohort study among HIV-positive individuals established to determine the ability of candidate kidney injury biomarkers to predict future hospitalized clinical AKI, to characterize hospitalized subclinical AKI, and to discern the risk of progressive kidney disease following subclinical and clinical AKI. Among the candidate kidney injury markers, we will select the most promising to translate into a clinically viable, multiplex panel of urinary biomarkers which we will integrate with clinical factors to develop a model prognostic of risks for AKI and subsequent kidney function decline. This study has a targeted enrollment of 2000 participants. The overall follow-up of participants consists of two phases: 1) a 5-year active follow-up phase which involves serial evaluations at enrollment, annual clinic visits, and among participants who are hospitalized during this period, an evaluation at index hospitalization and 3 and 12 months post-hospitalization; and 2) a subsequent passive follow-up phase for the duration that the participant receives medical care at The Johns Hopkins Hospital. Discussions: This study will serve as an important resource for future studies of AKI by establishing a repository with both ambulatory and inpatient biospecimens, a resource that is currently lacking in existing HIV clinical cohorts and studies of AKI. Upon completion of this study, the resulting prognostic model which will incorporate results from the multiplex HIV-AKI Risk Pane could serve as a pharmacodynamic endpoint for early phase therapeutic candidates for AKI.",
author = "{Corona Villalobos}, Celia and Shlipak, {Michael G.} and Adrienne Tin and Chirag Parikh and Moore, {Richard D} and Eric Vittinghoff and Jose Monroy-Trujillo and Mohamed Atta and Estrella, {Michelle M.}",
year = "2017",
month = "9",
day = "7",
doi = "10.1186/s12882-017-0696-1",
language = "English (US)",
volume = "18",
journal = "BMC Nephrology",
issn = "1471-2369",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Predictors of Acute Renal Injury Study (Paris) among HIV-positive individuals

T2 - Design and methods

AU - Corona Villalobos, Celia

AU - Shlipak, Michael G.

AU - Tin, Adrienne

AU - Parikh, Chirag

AU - Moore, Richard D

AU - Vittinghoff, Eric

AU - Monroy-Trujillo, Jose

AU - Atta, Mohamed

AU - Estrella, Michelle M.

PY - 2017/9/7

Y1 - 2017/9/7

N2 - Background: Acute kidney injury (AKI), which is common among HIV-positive individuals, may contribute to the excess burden of chronic kidney disease (CKD) in this patient population; however, conventional clinical methods to detect AKI do not capture kidney injury sufficiently early to prevent irreversible damage. Further, large observational and interventional studies of AKI generally exclude HIV-positive persons in spite of their disproportionate risk. Methods: The Predictors of Acute Renal Injury Study (Paris) is a prospective observational cohort study among HIV-positive individuals established to determine the ability of candidate kidney injury biomarkers to predict future hospitalized clinical AKI, to characterize hospitalized subclinical AKI, and to discern the risk of progressive kidney disease following subclinical and clinical AKI. Among the candidate kidney injury markers, we will select the most promising to translate into a clinically viable, multiplex panel of urinary biomarkers which we will integrate with clinical factors to develop a model prognostic of risks for AKI and subsequent kidney function decline. This study has a targeted enrollment of 2000 participants. The overall follow-up of participants consists of two phases: 1) a 5-year active follow-up phase which involves serial evaluations at enrollment, annual clinic visits, and among participants who are hospitalized during this period, an evaluation at index hospitalization and 3 and 12 months post-hospitalization; and 2) a subsequent passive follow-up phase for the duration that the participant receives medical care at The Johns Hopkins Hospital. Discussions: This study will serve as an important resource for future studies of AKI by establishing a repository with both ambulatory and inpatient biospecimens, a resource that is currently lacking in existing HIV clinical cohorts and studies of AKI. Upon completion of this study, the resulting prognostic model which will incorporate results from the multiplex HIV-AKI Risk Pane could serve as a pharmacodynamic endpoint for early phase therapeutic candidates for AKI.

AB - Background: Acute kidney injury (AKI), which is common among HIV-positive individuals, may contribute to the excess burden of chronic kidney disease (CKD) in this patient population; however, conventional clinical methods to detect AKI do not capture kidney injury sufficiently early to prevent irreversible damage. Further, large observational and interventional studies of AKI generally exclude HIV-positive persons in spite of their disproportionate risk. Methods: The Predictors of Acute Renal Injury Study (Paris) is a prospective observational cohort study among HIV-positive individuals established to determine the ability of candidate kidney injury biomarkers to predict future hospitalized clinical AKI, to characterize hospitalized subclinical AKI, and to discern the risk of progressive kidney disease following subclinical and clinical AKI. Among the candidate kidney injury markers, we will select the most promising to translate into a clinically viable, multiplex panel of urinary biomarkers which we will integrate with clinical factors to develop a model prognostic of risks for AKI and subsequent kidney function decline. This study has a targeted enrollment of 2000 participants. The overall follow-up of participants consists of two phases: 1) a 5-year active follow-up phase which involves serial evaluations at enrollment, annual clinic visits, and among participants who are hospitalized during this period, an evaluation at index hospitalization and 3 and 12 months post-hospitalization; and 2) a subsequent passive follow-up phase for the duration that the participant receives medical care at The Johns Hopkins Hospital. Discussions: This study will serve as an important resource for future studies of AKI by establishing a repository with both ambulatory and inpatient biospecimens, a resource that is currently lacking in existing HIV clinical cohorts and studies of AKI. Upon completion of this study, the resulting prognostic model which will incorporate results from the multiplex HIV-AKI Risk Pane could serve as a pharmacodynamic endpoint for early phase therapeutic candidates for AKI.

UR - http://www.scopus.com/inward/record.url?scp=85028974419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028974419&partnerID=8YFLogxK

U2 - 10.1186/s12882-017-0696-1

DO - 10.1186/s12882-017-0696-1

M3 - Article

C2 - 28882126

AN - SCOPUS:85028974419

VL - 18

JO - BMC Nephrology

JF - BMC Nephrology

SN - 1471-2369

IS - 1

M1 - 289

ER -